LENSAR (LNSR) Proxy Filing summary

Executive summary

• Announced a pending merger between LENSAR and Alcon, with LENSAR to become a wholly owned subsidiary of Alcon upon completion of the transaction.

• The Federal Trade Commission issued a Second Request for additional information, extending the antitrust review period under the HSR Act.

• Both parties expect to respond promptly to regulatory requests and anticipate closing the merger in the second half of 2025, subject to regulatory and shareholder approvals.

• Forward-looking statements highlight risks such as regulatory delays, failure to obtain shareholder approval, and potential legal proceedings.

Voting matters and shareholder proposals

• A special stockholder meeting has been announced to seek approval for the proposed merger.

• LENSAR has filed a proxy statement and related materials with the SEC for shareholder review.

• Directors, executive officers, and certain employees may participate in soliciting proxies for the merger.

Risk oversight and compliance

• The merger is subject to regulatory review, including compliance with the Hart-Scott-Rodino Act and FTC requirements.

• Risks include the possibility of the merger not closing, regulatory or legal challenges, and unanticipated costs or liabilities.

• Forward-looking statements are qualified by risk factors disclosed in prior SEC filings.